Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Ehrke

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Immunopharmacology|October 1, 1982
Augmentation of the phagocytic activity of murine spleen cell populations induced by AdriamycinS A Cohen, M J Ehrke, K Ryoyama, et al.
International Journal of Immunopharmacology|January 1, 1983
The effect of PS-K, a protein bound polysaccharide, on immune responses against allogeneic antigensM J Ehrke, J M Reino, C Eppolito, et al.
Cancer Research|June 1, 1986
Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allograftsM J Ehrke, C W Porter, C Eppolito, et al.
Journal of Immunopharmacology|January 1, 1980
Modification of mouse immune responses against allogeneic tumor by pretreatment of antigen with mitomycin C or X-irradiationC C Hoffmann, M J Ehrke, G Papp, et al.
International Archives of Allergy and Immunology|January 1, 1993
Polymyxin B-mediated lysis of tumor cellsS Verstovsek, D L Maccubbin, M J Ehrke, et al.
International Journal of Immunopharmacology|January 1, 1987
Low concentrations of thymidine modulate allogeneic responsesL Strzadala, D Maccubbin, K Ryoyama, et al.
Lymphokine and Cytokine Research|April 1, 1994
TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cellsP Ujházy, D Maccubbin, C Eppolito, et al.
Molecular Pharmacology|November 1, 1994
Doxorubicin-induced DNA degradation in murine thymocytesG Zaleskis, E Berleth, S Verstovsek, et al.
Cancer Research|August 1, 1989
Modification of host antitumor defense mechanisms in mice by progressively growing tumorD L Maccubbin, K F Mace, M J Ehrke, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1995
Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-lymphoma-bearing C57BL/6 miceC M Krawczyk, S Verstovsek, P Ujházy, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Immunopharmacology|October 1, 1982
Augmentation of the phagocytic activity of murine spleen cell populations induced by AdriamycinS A Cohen, M J Ehrke, K Ryoyama, et al.
International Journal of Immunopharmacology|January 1, 1983
The effect of PS-K, a protein bound polysaccharide, on immune responses against allogeneic antigensM J Ehrke, J M Reino, C Eppolito, et al.
Cancer Research|June 1, 1986
Selective modulation by alpha-difluoromethylornithine of T-lymphocyte and antibody-mediated cytotoxic responses to mouse tumor allograftsM J Ehrke, C W Porter, C Eppolito, et al.
Journal of Immunopharmacology|January 1, 1980
Modification of mouse immune responses against allogeneic tumor by pretreatment of antigen with mitomycin C or X-irradiationC C Hoffmann, M J Ehrke, G Papp, et al.
International Archives of Allergy and Immunology|January 1, 1993
Polymyxin B-mediated lysis of tumor cellsS Verstovsek, D L Maccubbin, M J Ehrke, et al.
International Journal of Immunopharmacology|January 1, 1987
Low concentrations of thymidine modulate allogeneic responsesL Strzadala, D Maccubbin, K Ryoyama, et al.
Lymphokine and Cytokine Research|April 1, 1994
TNF-alpha potentiation of the lymphokine-activated killer response of murine thymus cellsP Ujházy, D Maccubbin, C Eppolito, et al.
Molecular Pharmacology|November 1, 1994
Doxorubicin-induced DNA degradation in murine thymocytesG Zaleskis, E Berleth, S Verstovsek, et al.
Cancer Research|August 1, 1989
Modification of host antitumor defense mechanisms in mice by progressively growing tumorD L Maccubbin, K F Mace, M J Ehrke, et al.
Cancer Immunology, Immunotherapy : CII|June 1, 1995
Protective specific immunity induced by cyclophosphamide plus tumor necrosis factor alpha combination treatment of EL4-lymphoma-bearing C57BL/6 miceC M Krawczyk, S Verstovsek, P Ujházy, et al.
Pageof 6